SCHEMBL5505859

SCHEMBL5505859

COc1cc(F)c2nccc(C=Cc3ccccc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.49
KDM4E B2RXH2 3/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NFE2L2 Q16236 6/20 0.46
RELA Q04206 2/20 0.46
CNR1 P21554 2/20 0.45
CYP1A1 P04798 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP1B1 Q16678 2/20 0.45
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TRPV1 Q8NER1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505854 1.00 ALK (0.49) ALKKDM4EMAPK1NPSR1NFE2L2
SCHEMBL3278346 0.80 KDM4E (0.39) KDM4EMAPK1NPSR1CYP1A1CYP1A2
SCHEMBL3375976 0.80 CCR1 (0.49) KDM4EMAPK1NPSR1CYP1A1CYP1A2
SCHEMBL3375911 0.74 KDM4E (0.44) KDM4EMAPK1NPSR1CYP1A2ALDH1A1
SCHEMBL3375908 0.74 KDM4E (0.44) KDM4EMAPK1NPSR1CYP1A2ALDH1A1
SCHEMBL11545718 0.72 MAOB (0.43) ALKKDM4EMAPK1NPSR1NFE2L2
SCHEMBL11545174 0.72 MAOB (0.43) ALKKDM4EMAPK1NPSR1NFE2L2
SCHEMBL18544288 0.72 CCR1 (0.38) KDM4ECYP1A1CYP1A2CYP1B1MEN1
SCHEMBL4279169 0.72 NOS3 (0.43) KDM4ECYP1A1CYP1A2CYP1B1CYP3A4
SCHEMBL3375901 0.72 CCR1 (0.38) KDM4ECYP1A1CYP1A2CYP1B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed